Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation

N/ARecruitingNCT02023060

Sheba Medical Center100 enrolled

Overview

The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.

To observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Trans Catheter Aortic Valve Aortic Stenosis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 110 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Subject selected for transcatheter heart valve replacement 2. Signed informed consent to participate in the study Exclusion Criteria: 1. Inability to sign written informed consent. 2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).

Locations (5)

Hadassah Medical Center

Jerusalem, Israel

RECRUITING

Shaarei Zedek amedical Center

Jerusalem, Israel

RECRUITING

Rabin Medical Center

Petah Tikva, Israel

RECRUITING

Outcomes

Primary Outcomes

Clinical outcome of patients undergoing transcatheter valve replacement

Mortality, change in New York Heart Association class, change in ejection fraction.

Time frame: 12 months

Central Contacts

Israel Barbash, MD

CONTACT

+97235305273

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.